XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting  
Schedule of segment significant expense categories

    

Six Months Ended June 30, 

2025

2024

Grant income

$

12,192

$

12,223

Less:

 

 

Clinical programs

15,051

14,335

R&D Personnel costs(1)

4,973

5,221

Preclinical programs

225

525

Manufacturing

1,150

1,412

Other research and development expenses

227

124

General and administrative expenses(2)

4,920

4,845

Equity-based compensation

1,207

2,318

Other segment items(3)

 

(347)

 

(365)

Segment and consolidated net loss

$

(15,214)

$

(16,192)

(1) R&D Personnel costs exclude equity-based compensation

(2) General and administrative expenses exclude equity-based compensation

(3) Other segment items include, Other income, net, Interest expense and Loss on currency translation from liquidation of subsidiary.